Latest Margin Expansion News

Orica Limited posted its strongest half-year EBIT in over 20 years at $512 million, driven by premium product demand and strategic acquisitions including Nelson Brothers. The company also initiated a $100 million cost reduction program and declared a 28.5 cent interim dividend.

Amcor posted a 77% jump in Q3 net sales fueled by the Berry acquisition, delivering synergy gains above expectations and updating fiscal 2026 guidance amid geopolitical headwinds.

EVZ Limited projects full year revenue between $120 million and $125 million for FY26, alongside an EBITDA forecast of $8.5 million to $9 million, reflecting improved margins and operational efficiency.

Smartgroup delivered a robust start to 2026 with double-digit growth in novated leasing orders and a new app rollout, while targeting mid-40s EBITDA margins for 2027 amid supportive EV policies.

IMDEX Limited has delivered a record 3Q FY26 revenue increase of 29% in constant currency, fueled by strong global demand, strategic acquisitions, and AI-enabled mining technology solutions.

Judo Bank’s Q3 results show solid lending expansion, stable credit quality amid economic uncertainty, and reaffirmed FY26 guidance with a healthy capital buffer.

Resonance Health upgrades its FY26 underlying EBITDA guidance to $2.6 million, driven by operational efficiencies and growth in its Software-as-Medical Devices segment, despite a slight revenue timing delay.

Sports Entertainment Group (SEG) has upgraded its FY26 Underlying EBITDA guidance to a range of $15.5 million to $16.5 million, reflecting broad-based growth and operational efficiencies across its media and events businesses.

SSH Group Ltd is set to acquire Elphinstone Mechanical Services, boosting its revenue scale and geographic reach into Queensland and New South Wales with an immediately accretive deal.

X2M Connect is accelerating its transition to a high-margin SaaS model while trimming debt and growing its footprint across Asia-Pacific and the Middle East.

DUG Technology Ltd recorded a 35% revenue increase in FY26-Q3, surpassing full-year FY25 revenue in just nine months and announcing a strategic move to half-year financial reporting.

Resmed delivered a robust Q3 FY2026 with 11% revenue growth, margin expansion, and a 21% jump in non-GAAP EPS, while announcing a new U.S. distribution centre and a $0.60 dividend.